A smarter Europe
Introduction of a clinical study with an advanced cellular aHyC at interregional level
Typology: capitalization project
IIMMUNOCLUSTER-2 project addresses the strengthening of cross-border cooperation to improve the quality of life of the population.
- The general goal of the project is the initiation of a clinical trial for the treatment of triple negative breast cancer (TNBC) with a cell-based vaccine (aHyC) at the interregional level, to create the possibility of providing personalized advanced cancer therapies in an accessible and affordable way, to develop and improve innovation capabilities, and enabling the introduction of advanced technologies.
- Considering the existing situation, the project will promote innovation and improve technology transfer to SMEs, strengthen cooperation between innovative companies, research and healthcare institutions, and allow the capitalization of the results achieved in the previous project INTERREG ITASLO 2014-2020 Immuno-Cluster in a new integrated framework at regional level.
The main project outputs will be available soon.
Celica, biomedicinski center, d.o.o
Onkološki inštitut Ljubljana
Università degli studi di Udine
Azienda Sanitaria Universitaria Friuli Centrale
Zavod Republike Slovenije za transfuzijsko medicino
News and Events